TRTTrio-Tech International

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Siew W. Yong

Location

California, USA

Exchange

NYSE

Website

https://www.triotech.com

Summary

Trio-Tech International provides manufacturing, testing, and distribution services to semiconductor industry.

Company Info

CEO

Siew W. Yong

Location

California, USA

Exchange

NYSE

Website

https://www.triotech.com

Summary

Trio-Tech International provides manufacturing, testing, and distribution services to semiconductor industry.

AI Insights for TRT
5 min read

Quick Summary

Trio-Tech International is a small-cap U.S.-listed company that provides manufacturing, testing, and distribution services primarily for the semiconductor industry. The company is headquartered in Van Nuys, California, and operates under the ticker TRT on the NYSE. Its core business includes reliability and environmental testing services used by semiconductor companies to validate components before commercial deployment. The company also has a real estate segment that invests in and rents properties, which adds a non-semiconductor revenue stream. Its main customers are likely semiconductor manufacturers, electronics companies, component suppliers, and industrial customers that need outsourced testing, inspection, or support services.

Strengths

•

Trio-Tech’s main strength is its specialized exposure to semiconductor testing and reliability services, which are essential parts of the electronics supply chain.

•

The company offers a range of technical services such as thermal shock, burn-in, vibration, leak testing, and electrical testing, giving it relevance to customers with demanding qualification needs.

•

Its long operating history and focused technical capabilities may help it maintain customer relationships in a niche market.

•

The real estate segment provides some diversification outside the core semiconductor cycle.

•

The company also has a relatively small revenue base, which means even moderate contract wins or utilization improvements could have a noticeable impact on results.

Key Risks

•

The biggest risk is semiconductor cyclicality, because testing and manufacturing service demand can decline when chipmakers reduce production or delay new programs.

•

Trio-Tech also faces profitability risk because recent results show only near-break-even performance, and small changes in revenue or costs can affect earnings materially.

•

Competitive risk is significant because larger outsourced semiconductor service providers can offer scale, broader capabilities, and potentially lower pricing.

•

Liquidity and volatility are additional risks because the company has a small market capitalization and a high beta.

What to Watch

The most recent quarter provided in the data is fiscal Q4 2026.
During this quarter, Trio-Tech reported operating revenue of $16.511 million and total gross profit of $2.554 million.
The company recorded total operating income of negative $81,000 and net income of negative $37,000, indicating that it was close to break-even but not meaningfully profitable.
No specific company product launch, acquisition, partnership, or management change was included in the supplied company data for the quarter.
The supplied news items mostly relate to testosterone replacement therapy businesses and the healthcare meaning of TRT, so they do not appear to describe operational events at Trio-Tech International.

Price Drivers

•

Trio-Tech’s stock price is likely driven by semiconductor industry demand, quarterly revenue trends, profitability, and investor appetite for small-cap cyclical industrial stocks.

•

The most recent reported quarter shows operating revenue of about $16.5 million, gross profit of about $2.6 million, a small operating loss, and net income slightly below break-even, which suggests that margins and scale are important valuation issues.

•

The company’s market capitalization is about $106 million, and valuation metrics such as price-to-book of about 3.1 and EV-to-EBITDA above 28 indicate that investors may be pricing in improvement rather than current earnings strength.

•

The stock also has a high beta of about 1.98, meaning it may move sharply with broader market sentiment and semiconductor-related risk appetite.

•

Trading volume and momentum may matter because the company is relatively small, and small-cap stocks can experience outsized moves when news, liquidity, or earnings expectations change.

Recent News

•

The supplied recent news does not appear to be directly about Trio-Tech International.

•

Most of the headlines concern testosterone replacement therapy, men’s health clinics, telehealth platforms, oral testosterone products, and medical-device distribution involving companies unrelated to Trio-Tech.

•

These stories may appear because the acronym TRT is commonly used for testosterone replacement therapy, but they should not be treated as company-specific catalysts for Trio-Tech International.

•

No supplied news item describes a Trio-Tech acquisition, product launch, partnership, lawsuit, dividend change, or management announcement.

•

Based only on the provided information, the most relevant recent company-specific update is the financial data showing Q4 2026 revenue of $16.511 million and a small net loss.

Market Trends

•

The broader semiconductor market is the most important market trend affecting Trio-Tech International.

•

Demand for reliability testing can benefit from growth in automotive electronics, industrial automation, artificial intelligence hardware, data centers, and increasingly complex semiconductor devices.

•

At the same time, semiconductor inventory corrections, slower consumer electronics demand, and lower capital spending can reduce testing volumes and pressure margins.

•

The industry is also becoming more technically demanding, which may favor companies that can provide specialized, high-quality testing services.

•

The unrelated testosterone replacement therapy market is growing according to the supplied news, but that trend is not directly relevant to Trio-Tech International’s semiconductor and real estate businesses.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on TRT

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show